Study of Riamilovir Activity Against SARS-CoV-2 Infection In Syrian Hamsters

Study of Riamilovir Activity Against SARS-CoV-2 Infection In Syrian Hamsters

The activity of the antimetabolic drug Riamilovir (Triazavirin®) was studied on a model of SARS-CoV-2 infection on Syrian hamsters. Infectious process was caused by the intranasal administration of the virus accumulated in the Vero-B culture with a concentration of 4.25×104 TCID50, in a volume of 26...

Full description

Saved in:
Bibliographic Details
Main Authors: S. V. Chepur, A. V. Smirnova, A. N. Kirienko, I. A. Myasnikova, B. A. Kanevsky, P. V. Sorokin
Format: Article
Language:Russian
Published: LLC "Publishing House OKI" 2021-10-01
Series:Антибиотики и Химиотерапия
Subjects:
riamilovir
triazavirin
sars-cov-2
syrian hamsters
Online Access:https://www.antibiotics-chemotherapy.ru/jour/article/view/835
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items